Berlin - Berlin Delayed Price. Currency in EUR
86.73+0.50 (+0.58%)
At close: 2:08 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close86.23
Bid87.74 x 8800
Ask88.12 x 8700
Day's Range86.73 - 86.73
52wk Range68.75 - 125.65
1y Target EstN/A
Market CapN/A
P/E Ratio (ttm)N/A
Avg Vol (3m)0
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Barrons.com5 days ago

    Biotech Stocks: Oops, She Did It Again

    Yesterday, biotech stocks--including BioMarin Pharmaceutical (BMRN), Tesaro (TSRO), Vertex Pharmaceuticals (VRTX) and Celgene (CELG)--got pounded after Hillary Clinton tweeted that there was "no justification" for EpiPen price hikes, echoing what happened back in September 2015. RBC's Michael Yee and team consider the implications: The SPDR S&P Biotech index was down -4.3% today (vs SPX down -0.5%) and was one of the sharpest daily moves down in 8 weeks (i.e., Brexit) - but importantly, is after an already large +25% move since the Brexit bottom. Importantly, the sharp pullback was due mostly in our view to investor fear of more political risk around drug pricing concerns and potential changes in the future after Hillary Clinton tweeted "EpiPens can be the difference between life and death.

  • Vertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down
    Zacks14 days ago

    Vertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down

    Vertex's (VRTX) shares were down in pre-market trading on the company's announcement that it will be stopping one of the phase III studies on its VX-661-ivacaftor combination.

  • CNBC14 days ago

    After-hours buzz: HAIN, FN, VRTX & more

    Check out the companies making headlines after the bell on Monday.